Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02526576Phase 2Completed
A Phase 2 trial of autologous adipose stromal vascular fraction in Parry-Romberg syndrome (PRS), sponsored by Antria, Inc.. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02526576.